AB-Biotics is currently a leading biotechnology company based on research, development, intellectual protection and distribution of their own exclusive biotechnological solutions , focused on probiotics, through a Business to Business (B2B) model. From 2018 the international chemical company KANEKA CORPORATION joined the company capital. Now AB-Biotics and KANEKA join efforts to further develop probiotics science together. Worldwide pharmaceutical, dietary supplement and functional food industries are their main partners.
Kaneka’s probiotic effort includes the launch of the Floradapt™ line. Floradapt™ is a portfolio of science-based probiotic strains for targeted health applications, including Baby Colic, Cardio, Intensive G.I., Digestive, Oral Health and other products.